Swiss late-stage biotech Pharvaris saw its shares rise 17% to $28.24 today, as it announced RAPIDe-3 pivotal data confirming ...

Privately-held Imvax, a biotech developing personalized, whole tumor-derived immunotherapies, has announced top line results ...

Shares of San Diego, USA-based Janux Therapeutics slumped 53% to $15.86 on Tuesday after several analysts lowered their price ...

Japanese drugmaker Eisai and US biotech Biogen announced new data confirming the pharmacological effect of Leqembi (lecanemab ...

Taiwanese biotech Formosa Pharmaceuticals (TWSE: 6838) has signed an exclusive agreement with Singapore-based Rxilient ...

The US Food and Drug Administration’s (FDA) director of its Center for Drug Evaluation and Research (CDER) is to retire at ...

A French biotech developing therapies for neurodegenerative disease, with its lead program aimed at amyotrophic lateral ...

Danish allergy immunotherapy specialist ALK-Abello has appointed Edward Jordan as new executive vice president (EVP) and head ...

Sun Pharmaceutical Industries has announced the launch of its global innovative drug, Ilumya (tildrakizumab) in India for ...

German pharma major Bayer has announced the start of its Phase III study SUNFLOWER, an investigational study evaluating the ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Tivdak (tisotumab vedotin) used for the ...

Actithera has appointed radiopharmaceutical specialist Darshan Dalal as chief medical officer as the Norwegian and American ...